Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 19 May 2023

Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease

in Respiratory Pharmacology

Hua Ye
Beibei He
Yujie Zhang
Ziwei Yu
Yifan Feng
Chuanbiao Wen
Chongcheng Xi
Quansheng Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1117238

5,236 views
9 citations

Original Research

Published on 18 May 2023

The identification of metabolism-related subtypes and potential treatments for idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Changqing Yang
Guixin Wang
Wenyu Zhan
Yubao Wang
Jing Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1173961

4,956 views
4 citations

Review

Published on 16 May 2023

Perspectives on precision cut lung slices—powerful tools for investigation of mechanisms and therapeutic targets in lung diseases

in Respiratory Pharmacology

Maggie Lam
Emma Lamanna
Louise Organ
Chantal Donovan
Jane E. Bourke

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1162889

13,722 views
39 citations

Review

Published on 11 May 2023

Herbal medicine for the treatment of obesity-associated asthma: a comprehensive review

in Respiratory Pharmacology

Aparoop Das
Manash Pratim Pathak
Kalyani Pathak
Riya Saikia
Urvashee Gogoi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1186060

9,489 views
8 citations

Original Research

Published on 05 May 2023

Efficacy of a paper-based interleukin-6 test strip combined with a spectrum-based optical reader for sequential monitoring and early recognition of respiratory failure in elderly pneumonia—a pilot study

in Respiratory Pharmacology

Cheng-Han Chen
Yi-Chen Fu
Yi-Tzu Lee
Kai-Sheng Hsieh
Ching-Fen Shen
Chao-Min Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1166923

3,338 views
2 citations

Case Report

Published on 04 May 2023

Case Report: Nintedanib for immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with SMARCA4-mutant NSCLC: a case report

in Respiratory Pharmacology

Changwen Deng
Ganxiu Deng
Xiaoping Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1177329

3,529 views
2 citations

Correction

Published on 03 May 2023

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score

in Respiratory Pharmacology

Jochen G. Mainz
Carlos Zagoya
Louise Polte
Lutz Naehrlich
Lenny Sasse
Olaf Eickmeier
Christina Smaczny
Anton Barucha
Lilith Bechinger
Franziska Duckstein

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207356

1,753 views

Original Research

Published on 24 Apr 2023

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension

in Respiratory Pharmacology

Isabel Blanco
Maribel Marquina
Olga Tura-Ceide
Elisabet Ferrer
Ana M. Ramírez
Manuel Lopez-Meseguer
Maria Callejo
Francisco Perez-Vizcaino
Victor Ivo Peinado
Joan Albert Barberà

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1145994

4,178 views
5 citations

Original Research

Published on 17 Apr 2023

The performance of metagenomic next-generation sequencing in diagnosing pulmonary infectious diseases using authentic clinical specimens: The Illumina platform versus the Beijing Genomics Institute platform

in Respiratory Pharmacology

Shuangyu Han
Zhan Zhao
Lei Yang
Jie Huang
Yubao Wang
Jing Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164633

3,822 views
5 citations

Original Research

Published on 11 Apr 2023

The effect of CFTR modulators on structural lung disease in cystic fibrosis

in Respiratory Pharmacology

L. Clara Mok
Antonio Garcia-Uceda
Matthew N. Cooper
Mariette Kemner-Van De Corput
Marleen De Bruijne
Nathalie Feyaerts
Tim Rosenow
Kris De Boeck
Stephen Stick
Harm A. W. M. Tiddens

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1147348

4,507 views
10 citations

Original Research

Published on 10 Apr 2023

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging

in Respiratory Pharmacology

Lena Wucherpfennig
Felix Wuennemann
Monika Eichinger
Angelika Seitz
Ingo Baumann
Mirjam Stahl
Simon Y. Graeber
Shengkai Zhao
Jaehi Chung
Jens-Peter Schenk

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1161891

3,295 views
9 citations

Original Research

Published on 04 Apr 2023

Low-dose of caffeine alleviates high altitude pulmonary edema via regulating mitochondrial quality control process in AT1 cells

in Respiratory Pharmacology

Liuyang Tian
Zhilong Jia
Yan Yan
Qian Jia
Wenjie Shi
Saijia Cui
Huining Chen
Yang Han
Xiaojing Zhao
Kunlun He

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155414

6,804 views
5 citations

Review

Published on 30 Mar 2023

Sex chromosome complement and sex steroid signaling underlie sex differences in immunity to respiratory virus infection

in Respiratory Pharmacology

Reegan A. J. Miller
Abigael P. Williams
Susan Kovats

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1150282

6,061 views
11 citations

Original Research

Published on 29 Mar 2023

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

in Respiratory Pharmacology

Daniel Morales-Cano
Jose Luis Izquierdo-García
Bianca Barreira
Sergio Esquivel-Ruiz
Maria Callejo
Rachele Pandolfi
Palmira Villa-Valverde
Ignacio Rodríguez
Angel Cogolludo
Jesus Ruiz-Cabello

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1021535

5,291 views
5 citations

Review

Published on 21 Mar 2023

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor

in Respiratory Pharmacology

Burkhard Tümmler

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1158207

11,386 views
19 citations

Clinical Trial

Published on 21 Mar 2023

Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China

in Respiratory Pharmacology

Ling Lin
Cong Liu
Wei Cheng
Qing Song
Yuqin Zeng
Xin Li
Dingding Deng
Dan Liu
Yan Chen
Shan Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1147985

5,915 views
16 citations

Review

Published on 16 Mar 2023

Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases

in Respiratory Pharmacology

Miquéias Lopes-Pacheco
Patricia R. M. Rocco

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1067422

9,825 views
17 citations

Original Research

Published on 16 Mar 2023

Better response to Tanreqing injection in frequent acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients—Real-world evidence from a nationwide registry (ACURE) study

in Respiratory Pharmacology

Guohui Fan
Dingyi Wang
Sinan Wu
Demin Li
Xiaoxia Ren
Fen Dong
Kewu Huang
Yahong Chen
Hongchun Zhang
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118143

3,734 views
2 citations

Review

Published on 16 Mar 2023

The protective effects of baicalin for respiratory diseases: an update and future perspectives

in Respiratory Pharmacology

Siyu Song
Lu Ding
Guangwen Liu
Tian Chen
Meiru Zhao
Xueyan Li
Min Li
Hongyu Qi
Jinjin Chen
Ziyuan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1129817

12,255 views
16 citations

Original Research

Published on 14 Mar 2023

Artesunate inhibits airway remodeling in asthma via the MAPK signaling pathway

in Respiratory Pharmacology

Mengyuan Zhang
Jiangtao Lin
Jingyuan Zhang
Ruiheng Zhao
Jingxuan Wan
Ying Nong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1145188

5,408 views
16 citations

Original Research

Published on 14 Mar 2023

Arctiin-encapsulated DSPE-PEG bubble-like nanoparticles inhibit alveolar epithelial type 2 cell senescence to alleviate pulmonary fibrosis via the p38/p53/p21 pathway

in Respiratory Pharmacology

Dian Xiong
Fei Gao
Jingbo Shao
Yueyun Pan
Song Wang
Dong Wei
Shugao Ye
Yuan Chen
Rui Chen
Bingqing Yue

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141800

6,649 views
16 citations

Perspective

Published on 09 Mar 2023

Current possibilities and future opportunities provided by three-dimensional lung ECM-derived hydrogels

in Respiratory Pharmacology

Mehmet Nizamoglu
Janette K. Burgess

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154193

3,836 views
8 citations

Original Research

Published on 09 Mar 2023

Sex-specific non-linear associations between body mass index and impaired pulmonary ventilation function in a community-based population: Longgang COPD study

in Respiratory Pharmacology

Hao Huang
Xueliang Huang
Jiaman Liao
Yushao Li
Yaoting Su
Yaxian Meng
Yiqiang Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1103573

3,344 views
2 citations

Original Research

Published on 09 Mar 2023

Urolithin A (UA) attenuates ferroptosis in LPS-induced acute lung injury in mice by upregulating Keap1-Nrf2/HO-1 signaling pathway

in Respiratory Pharmacology

Lejing Lou
Min Wang
Jingjing He
Song Yang
Fanxi Meng
Shijia Wang
Xiao Jin
Jihao Cai
Chang Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1067402

17,357 views
50 citations